guest ::
| Home > Publications Database > Cell-in-cell structure mediates in-cell killing suppressed by CD44. > print |
| Home > Publications Database > Cell-in-cell structure mediates in-cell killing suppressed by CD44. > print |
| 001 | 163946 | ||
| 005 | 20230915090538.0 | ||
| 024 | 7 | _ | |a 10.1038/s41421-022-00387-1 |2 doi |
| 024 | 7 | _ | |a pmid:35436988 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC9016064 |2 pmc |
| 024 | 7 | _ | |a altmetric:126905888 |2 altmetric |
| 037 | _ | _ | |a DZNE-2022-00620 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Su, Yan |b 0 |
| 245 | _ | _ | |a Cell-in-cell structure mediates in-cell killing suppressed by CD44. |
| 260 | _ | _ | |a London |c 2022 |b Nature Publishing Group |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1655122286_6958 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Penetration of immune cells into tumor cells was believed to be immune-suppressive via cell-in-cell (CIC) mediated death of the internalized immune cells. We unexpectedly found that CIC formation largely led to the death of the host tumor cells, but not the internalized immune cells, manifesting typical features of death executed by NK cells; we named this 'in-cell killing' which displays the efficacy superior to the canonical way of 'kiss-killing' from outside. By profiling isogenic cells, CD44 on tumor cells was identified as a negative regulator of 'in-cell killing' via inhibiting CIC formation. CD44 functions to antagonize NK cell internalization by reducing N-cadherin-mediated intercellular adhesion and by enhancing Rho GTPase-regulated cellular stiffness as well. Remarkably, antibody-mediated blockade of CD44 signaling potentiated the suppressive effects of NK cells on tumor growth associated with increased heterotypic CIC formation. Together, we identified CIC-mediated 'in-cell killing' as a promising strategy for cancer immunotherapy. |
| 536 | _ | _ | |a 351 - Brain Function (POF4-351) |0 G:(DE-HGF)POF4-351 |c POF4-351 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de |
| 700 | 1 | _ | |a Huang, Hongyan |0 0000-0001-8340-6660 |b 1 |
| 700 | 1 | _ | |a Luo, Tianzhi |b 2 |
| 700 | 1 | _ | |a Zheng, You |b 3 |
| 700 | 1 | _ | |a Fan, Jie |b 4 |
| 700 | 1 | _ | |a Ren, He |b 5 |
| 700 | 1 | _ | |a Tang, Meng |b 6 |
| 700 | 1 | _ | |a Niu, Zubiao |b 7 |
| 700 | 1 | _ | |a Wang, Chenxi |b 8 |
| 700 | 1 | _ | |a Wang, Yuqi |b 9 |
| 700 | 1 | _ | |a Zhang, Zhengrong |b 10 |
| 700 | 1 | _ | |a Liang, Jianqing |b 11 |
| 700 | 1 | _ | |a Ruan, Banzhan |b 12 |
| 700 | 1 | _ | |a Gao, Lihua |b 13 |
| 700 | 1 | _ | |a Chen, Zhaolie |b 14 |
| 700 | 1 | _ | |a Melino, Gerry |0 P:(DE-2719)9001390 |b 15 |u dzne |
| 700 | 1 | _ | |a Wang, Xiaoning |b 16 |
| 700 | 1 | _ | |a Sun, Qiang |0 0000-0002-5342-0637 |b 17 |
| 773 | _ | _ | |a 10.1038/s41421-022-00387-1 |g Vol. 8, no. 1, p. 35 |0 PERI:(DE-600)2842548-0 |n 1 |p 35 |t Cell discovery |v 8 |y 2022 |x 2056-5968 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/163946/files/DZNE-2022-00620.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/163946/files/DZNE-2022-00620.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:163946 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 15 |6 P:(DE-2719)9001390 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Neurodegenerative Diseases |1 G:(DE-HGF)POF4-350 |0 G:(DE-HGF)POF4-351 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Brain Function |x 0 |
| 914 | 1 | _ | |y 2022 |
| 915 | _ | _ | |a Creative Commons Attribution CC BY (No Version) |0 LIC:(DE-HGF)CCBYNV |2 V:(DE-HGF) |b DOAJ |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2021-05-04 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2021-05-04 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2021-05-04 |
| 915 | _ | _ | |a Fees |0 StatID:(DE-HGF)0700 |2 StatID |d 2021-05-04 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Article Processing Charges |0 StatID:(DE-HGF)0561 |2 StatID |d 2021-05-04 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL DISCOV : 2021 |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-02-14T16:20:07Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-02-14T16:20:07Z |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2021-02-14T16:20:07Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-29 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-29 |
| 915 | _ | _ | |a IF >= 30 |0 StatID:(DE-HGF)9930 |2 StatID |b CELL DISCOV : 2021 |d 2022-11-29 |
| 920 | 1 | _ | |0 I:(DE-2719)5000018 |k AG Nicotera |l Synaptic Connectivity and Neurodegeneration |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)5000018 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|